These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2136722

  • 41. Inotropic agents.
    Vincent JL, Preiser JC.
    New Horiz; 1993 Feb; 1(1):137-44. PubMed ID: 7922387
    [Abstract] [Full Text] [Related]

  • 42. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M, Rochiccioli JP, Edouard P, Fourcade J, Massabuau P, Puel J, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [Abstract] [Full Text] [Related]

  • 43. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
    Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R.
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
    [Abstract] [Full Text] [Related]

  • 44. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
    Noori S, Seri I.
    Clin Perinatol; 2012 Mar; 39(1):221-38. PubMed ID: 22341548
    [Abstract] [Full Text] [Related]

  • 45. Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
    J Cardiovasc Pharmacol; 1989 Mar; 14 Suppl 1():S1-S83. PubMed ID: 2480479
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Rational use of catecholamines and inotropes].
    Hewing B, Stangl K.
    Pneumologie; 2007 Nov; 61(11):700-8. PubMed ID: 17929214
    [Abstract] [Full Text] [Related]

  • 49. Pharmacologic hemodynamic support in massive pulmonary embolism.
    Layish DT, Tapson VF.
    Chest; 1997 Jan; 111(1):218-24. PubMed ID: 8996020
    [No Abstract] [Full Text] [Related]

  • 50. Cardiovascular pharmacotherapy update for the intensive care unit.
    Coons JC, Seidl E.
    Crit Care Nurs Q; 2007 Jan; 30(1):44-57. PubMed ID: 17198036
    [Abstract] [Full Text] [Related]

  • 51. [Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery].
    George M, Atallah G, Lehot JJ, Bastien O, Durand PG, Estanove S.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():57-62. PubMed ID: 2147836
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Phosphodiesterase inhibitors: the inotropes of choice for the new millennium?
    Levy JH, Bailey JM.
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):365-6. PubMed ID: 10972597
    [No Abstract] [Full Text] [Related]

  • 54. [Intravenous enoximone versus conventional treatment in acute lung edema. Preliminary results of a randomized study].
    Flammang D, Waynberger M, Chassing A, Tarral A.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():39-42. PubMed ID: 2147833
    [Abstract] [Full Text] [Related]

  • 55. The phosphodiesterase-inhibitor enoximone--a new concept in the therapy of patients with impaired myocardial function in cardiac surgery.
    Boldt J, Kling D, Hempelmann G.
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):10. PubMed ID: 2535299
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA, Johnson DC.
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.